Jae H. Park, MD

Jae Park, MD, discussed the use of CAR T-cell therapy across the hematologic malignancies space.

There has been dramatic progress in the management of acute promyelocytic leukemia during the past three decades. Important insights into the pathogenesis of the disease have come to light and effective treatment has been developed.